INDUSTRY NEWS Clavis Pharma and Clovis Oncology Extend Partnership and Sign New $205 Million Deal for the Development and Commercialization of Anti-Cancer Agent CP-4126 in Asia and Rest of the World Clavis Pharma ASA and Clovis Oncology, Inc. announced a new agreement for the further development and commercialization of CP-4126 (also known as CO-101), which is currently in Phase II development in pancreatic cancer. [Clavis Pharma Press Release] London Genetics and Astrimmune to Find Predictive Biomarkers for Pancreatic Cancer Vaccine London Genetics and Astrimmune will work together to establish a biomarker identification program for the latter’s pancreatic cancer vaccine candidate. [Genetic Engineering and Biotechnology News] Bristol-Myers Squibb Foundation Launches $100 Million Initiative Targeting America’s Type 2 Diabetes Crisis The Bristol-Myers Squibb Foundation announced Together on Diabetes®: Communities Uniting to Meet America’s Diabetes Challenge, a 5-year, $100 million initiative to help patients living with type 2 diabetes better manage their disease beyond the doors of their doctor’s office — in their homes and communities — and for the course of their disease. [Bristol-Myers Squibb Foundation Press Release] Xoma Issued Two New U.S. Patents Covering XOMA 052 Xoma Ltd. announced that the U.S. Patent and Trademark Office issued two new patents to Xoma as part of the company’s expanding intellectual property portfolio around its XOMA 052 antibody to interleukin-1 beta. [Xoma Ltd. Press Release] Access Pharmaceuticals Presents CobOral™ Insulin Research at 10th Annual Diabetes Technology Meeting Access Pharmaceuticals, Inc. announced that it presented a poster at the 10th Annual Diabetes Technology Meeting, entitled, “Preclinical Studies with Cobalamin™ Nanoparticles for Oral Drug Delivery of Insulin.” [Access Pharmaceuticals, Inc. Press Release] Biodel Reports New Findings from Key Programs at Diabetes Technology Meeting Scientists from Biodel Inc. reported new findings from the company’s Linjeta™, insulin glargine, “smart” basal insulin and stabilized glucagon development programs in poster presentations at the 10th Annual Diabetes Technology Meeting in Bethesda, MD. [Biodel Inc. Press Release] Halozyme’s rHuPH20 with Recombinant Human Insulin Demonstrates Glycemic Control Comparable to Lispro Halozyme Therapeutics, Inc. announced Phase II results demonstrating that Insulin-PH20 (recombinant human insulin with rHuPH20) produced glycemic control comparable to lispro. [Halozyme Therapeutics, Inc. Press Release] Biomedical Warp Knit Project Aids Diabetes Research Narrow fabrics machinery manufacturer Comez has developed an innovative electronic double needle bar warp knitting machine for use in an Italian regional government funded biomedical textiles project. The Panagenesi project aims to help cure diabetes by optimizing the implanting of human pancreatic islands through the use of fibrin scaffold to aid in the success of pancreatic transplants. [Knitting Industry] Boston Scientific Announces Sponsorship of World Diabetes Day Campaign 2010 Boston Scientific Corporation announced its sponsorship of “World Diabetes Day” for the third year in a row. The campaign is led by the International Diabetes Federation and represents its primary global awareness initiative in the fight against diabetes. [Boston Scientific Corporation Press Release]
|
|
EVENTS (Listed by Date) Pharmacology in Stem Cells Research and Regenerative Medicine December 17, 2010 London, United Kingdom NEW The 3rd Guangzhou International Conference on Stem Cell Biology and Regenerative Medicine December 17-19, 2010 Guangzhou, China Type 2 Diabetes, Insulin Resistance and Metabolic Dysfunction January 12-17, 2011 Dillon, United States Keystone Symposia: Obesity January 12-17, 2011 Keystone, United States 2011 Gastrointestinal Cancers Symposium January 20-22, 2011 San Francisco, United States Keystone Symposia: Epithelial Plasticity and Epithelial to Mesenchymal Transition January 21-26, 2011 Vancouver, Canada 5th Annual Stem Cells and Regenerative Medicine World Congress January 24-25, 2011 San Diego, United States Phacilitate 7th Annual Cell & Gene Therapy Forum 2011 January 24-26, 2011 Washington, D.C., United States Early Development for Innovative Diabetes & Metabolic Syndrome Therapeutics Conference January 26-27, 2011 Amsterdam, The Netherlands Joint Conference of the International Association of Pancreatology and the Indian Pancreas Club February 10-13, 2011 Maradu, India NEW 2nd Annual International Diabetes Summit February 22-24, 2011 Dubai, United Arab Emirates United Kingdom National Stem Cell Network 2011 Annual Scientific Conference March 30-April 1, 2011 York, United Kingdom American Association for Cancer Research (AACR) 102nd Annual Meeting 2011 April 2-6, 2011 Orlando, United States 13th Annual C21 BioVentures May 24-26, 2011 Napa, United States European Pancreatic Club Meeting 2011 June 22-25, 2011 Magdeburg, Germany PancreasFest 2011 July 28-30, 2011 Pittsburgh, United States Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.
JOB OPPORTUNITIES Lab Technologist – Human Embryonic and Induced Pluripotent Stem Cells (STEMCELL Technologies) Lab Technologist – Tissue Culture (STEMCELL Technologies) Product Manager – Pluripotent Stem Cells (STEMCELL Technologies) Recruit Top Talent Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Cell Therapy News at no cost. Visit here to post your career opportunities.
Have we missed an important article or publication in Pancreatic Cell News? Click here to submit! |
| |
|